While Masimo Corporation (NASDAQ:MASI) might not have the largest market cap around , it saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS. The recent rally ...

According to Benzinga Pro, Masimo's peer group average for short interest as a percentage of float is 4.99%, which means the ...

Masimo Corporation refocuses on healthcare, projecting 8-11% growth by 2025. Click for why despite progress and solid ...

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Masimo with a $189.60 average price target, representing a 14.67% upside. In a report released on May 30, Wells ...

A new study found that EEG-guided anesthesia using Masimo SedLine® improved anesthesia administration in children undergoing surgery.

Masimo Corporation (NASDAQ:MASI), currently trading at $150.13 and showing strong liquidity with a current ratio of 2.17, announced today that it expects the recent cybersecurity incident to have ...

"We initiated a position in Masimo Corporation (NASDAQ:MASI), a medical device company that manufactures and sells a variety of non-invasive patient monitoring technologies. Masimo is the market ...

Medical device company Masimo Corporation warns that a cyberattack is impacting production operations and causing delays in fulfilling customers' orders. Masimo Corporation is a California-based ...

Irvine, CA-based Masimo Corporation (NASDAQ:MASI), a medical technology company with a market capitalization of $9.4 billion and a "GOOD" financial health rating according to InvestingPro ...

Masimo SET ® Measure-through Motion and Low Perfusion ™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...